[Biochemical, pharmacological and clinical observations in connection with the broncho-secretolytic, bisolvon].
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D000643:Ammonium Chloride / Q000627:therapeutic use*; D000814:Aniline Compounds / Q000627:therapeutic use*; D001593:Benzyl Compounds / Q000627:therapeutic use; D001987:Bronchiectasis / Q000188:drug therapy; D001991:Bronchitis / Q000188:drug therapy; D003510:Cyclohexanes / Q000627:therapeutic use; D005100:Expectorants / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008169:Lung Abscess / Q000188:drug therapy; D008171:Lung Diseases / Q000188:drug therapy*; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011014:Pneumonia / Q000188:drug therapy; D011658:Pulmonary Fibrosis / Q000188:drug therapy; D013997:Time Factors
D000814:Aniline Compounds; D001593:Benzyl Compounds; D003510:Cyclohexanes; D005100:Expectorants; D000643:Ammonium Chloride
Biochemische, pharmakologische und klinische Betrachtungen in Verbindung mit dem Broncho-Sekretolytikum Bisolvon.